Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Phase II, Exploratory Evaluation of ALGRX 4975 in Subjects With Acute Lateral Epicondylitis

NCT00130949 is registered in ClinicalTrials.gov with AlgoRx Pharmaceuticals as lead sponsor.

NCT NCT00130949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Phase II, Exploratory Evaluation of ALGRX 4975 in Subjects With Acute Lateral Epicondylitis
Lead sponsor
AlgoRx Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2004
Completion date
November 30, 2005
Enrollment
45
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tennis elbow